Lakefront Biotherapeutics (LKFT) Profit After Tax (QoQ) (2016 - 2026)
Lakefront Biotherapeutics (LKFT) Profit After Tax (QoQ) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Lakefront Biotherapeutics | 1.86 Bn | -1.54 Bn | 1.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -98.22% |
| Dec 31, 2025 | 269.62% |
| Sep 30, 2025 | -398.64% |
| Jun 30, 2025 | 199.90% |
| Mar 31, 2025 | -710.71% |
| Dec 31, 2024 | 213.66% |
| Sep 30, 2024 | -146.84% |
| Jun 30, 2024 | 102.26% |
| Mar 31, 2024 | -86.61% |
| Dec 31, 2023 | 303.24% |
| Sep 30, 2023 | 1,017.25% |
| Jun 30, 2023 | 134.79% |
| Mar 31, 2023 | 94.60% |
| Dec 31, 2022 | -1,063.04% |
| Sep 30, 2022 | 213.08% |
| Jun 30, 2022 | -42.96% |
| Mar 31, 2022 | 75.79% |
| Dec 31, 2021 | 61.24% |
| Sep 30, 2021 | -120.43% |
| Jun 30, 2021 | -402.57% |